Core Laboratories Inc. (NYSE:CLB – Get Free Report)’s share price gapped up prior to trading on Thursday after the company announced better than expected quarterly earnings. The stock had previously closed at $17.08, but opened at $17.84. Core Laboratories shares last traded at $18.51, with a volume of 15,426 shares traded.
The oil and gas company reported $0.25 EPS for the quarter, beating the consensus estimate of $0.21 by $0.04. Core Laboratories had a return on equity of 15.20% and a net margin of 5.44%. The business had revenue of $134.40 million for the quarter, compared to the consensus estimate of $134.16 million. During the same period in the previous year, the business earned $0.22 earnings per share. The business’s revenue was up 7.2% on a year-over-year basis.
Core Laboratories Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 25th. Shareholders of record on Monday, November 4th will be issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.21%. The ex-dividend date of this dividend is Monday, November 4th. Core Laboratories’s dividend payout ratio (DPR) is currently 4.55%.
Wall Street Analyst Weigh In
View Our Latest Stock Analysis on Core Laboratories
Institutional Trading of Core Laboratories
A number of large investors have recently made changes to their positions in CLB. Headlands Technologies LLC purchased a new position in Core Laboratories in the second quarter worth about $36,000. nVerses Capital LLC bought a new stake in shares of Core Laboratories in the 3rd quarter valued at approximately $48,000. GAMMA Investing LLC boosted its holdings in shares of Core Laboratories by 23.9% in the 2nd quarter. GAMMA Investing LLC now owns 4,425 shares of the oil and gas company’s stock worth $90,000 after purchasing an additional 855 shares during the period. Platinum Investment Management Ltd. increased its position in shares of Core Laboratories by 13.9% during the 1st quarter. Platinum Investment Management Ltd. now owns 6,351 shares of the oil and gas company’s stock valued at $108,000 after purchasing an additional 774 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. raised its holdings in Core Laboratories by 11.9% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 5,636 shares of the oil and gas company’s stock valued at $114,000 after buying an additional 600 shares during the period. 97.81% of the stock is currently owned by institutional investors.
Core Laboratories Stock Performance
The company has a debt-to-equity ratio of 0.60, a current ratio of 2.39 and a quick ratio of 1.68. The business has a 50-day moving average of $18.53 and a 200-day moving average of $18.97. The company has a market capitalization of $911.74 million, a P/E ratio of 22.09, a P/E/G ratio of 1.08 and a beta of 2.36.
About Core Laboratories
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
See Also
- Five stocks we like better than Core Laboratories
- Upcoming IPO Stock Lockup Period, Explained
- Texas Roadhouse Stock Steering for New Highs This Year
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- What is a Dividend King?
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.